Ketamine is an NMDA receptor antagonist with a potent anesthetic effect. It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories. It started being used for veterinary purposes in Belgium and in 1964 was proven that compared to PCP, it produced minor hallucinogenic effects and shorter psychotomimetic eff...
Ketamine is indicated as an anesthetic agent for recommended diagnostic and surgical procedures. If skeletal muscle relaxation is needed, it should be combined with a muscle relaxant. If the surgical procedure involves visceral pain, it should be supplemented with an agent that obtunds visceral pain. Ketamine can be used for induction of anesthesia prior oth...
The Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
Faculty of medicine -Al-Azhar university, Cairo, Egypt
Rush University Medical Center, Chicago, Illinois, United States
Karelsheikh University Hospital, Kafr Ash Shaykh, Karelsheikh, Egypt
Treviso Regional Hospital, Treviso, TV, Italy
VA Connecticut Healthcare System, West Haven, Connecticut, United States
Sohag University Hospital, Sohag, Egypt
Ospedale Santa Chiara Trento, Trento, TN, Italy
Ospedale G. Brotzu, Cagliari, CA, Italy
Azienda Ospedaliero-Universitaria di Modena, Modena, MO, Italy
Sohag University Hospital, Sohag, Egypt
Istanbul Training and Research Hospital, Istanbul, Fatih, Turkey
IstanbulTRH, Istanbul, Turkey
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.